Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Total Current Liabilities (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) posted Total Current Liabilities of $873,000 for Q2 2026, down 13.9% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics' Total Current Liabilities came in at $605,000, up 109.3% from FY2024.

  • In prior years, Polaryx Therapeutics' Total Current Liabilities was $289,000 in FY2024.
  • Quarterly Total Current Liabilities has run from a low of $289,000 in Q4 2024 to a high of $1.01 million in Q1 2026 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - 873,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 873,000.00
Mar 31, 2026 1.01 Mn
Dec 31, 2025 605,000.00
Dec 31, 2024 289,000.00
API Access

Polaryx Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PLYX&period=max&api_key=YOUR_API_KEY